Mahon Paul A's Form 4/A amendment
AmendedUnited Therapeutics Corp (UTHR) · filed Mar 4, 2022
- Accession no.
- 0001127602-22-008274
- Filed
- Mar 4, 2022
- Trade date
- Jan 6, 2022
- Filing delay
- 57 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 6, 2022
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.15M. It was filed 57 days after the trade.
This amendment replaces 0001127602-22-001100 (filed Jan 6, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2022 | Common Stock | MOption exerciseAcquired | +6,000 | $111.00 | +$666,000 | 42,369 | Direct | |
| Jan 6, 2022 | Common Stock | SSaleDisposed | −320 | $190.48F3 | −$60,953.6 | 42,049 | Direct | |
| Jan 6, 2022 | Common Stock | SSaleDisposed | −2,970 | $192.32F4 | −$571,190.4 | 39,079 | Direct | |
| Jan 6, 2022 | Common Stock | SSaleDisposed | −2,710 | $192.85F5 | −$522,623.5 | 36,369 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2022 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 1,094 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2
This acquisition of common stock was inadvertently omitted from Table I on the original filing due to administrative error, although the corresponding option exercise was included on Table II. As a result, three subsequent Form 4 filings also incorrectly understated the reporting person's common stock balance by 6,000 shares (filed on January 20, 2022, February 3, 2022, and February 17, 2022).
- F3
This transaction was executed in multiple trades at prices ranging from $190.32 to $190.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $191.65 to $192.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $192.65 to $193.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
The reporting person received two stock option grants, both with the same grant date and exercise price. Due to administrative error, previous option exercises occasionally were reported on Table II as having been drawn from the wrong tranche. This balance has been updated to correct these errors.